CoChat

Omega-3 Fatty Acid Supplementation and Coronary Heart Disease Risks: A Meta-Analysis of Randomized Controlled Clinical Trials

Shen, ShiChun, Gong, Chen, Jin, KaiQin, Zhou, Lei, Xiao, Yin, Ma, Likun · 2022 · Frontiers in Nutrition
Cited by 59

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

Background: The clinical benefits of omega-3 fatty acids (FAs) supplementation in preventing and treating coronary heart disease (CHD) remain controversial. Therefore, this study aimed to investigate the clinical benefits of omega-3 FA supplementation, with special attention given to specific subgroups. Methods: Randomized controlled trials (RCTs) that compared the effects of omega-3 FA supplementation for CHD vs. a control group and including at least 1,000 patients were eligible for the inclusion in this meta-analysis. The relative risk (RR) of all-cause death, major adverse cardiovascular events (MACEs), cardiovascular death, myocardial infarction (MI), stroke, and revascularization were estimated. We analyzed the association between cardiovascular risk and omega-3 FA supplementation in the total subjects. We focused on the cardiovascular risk compared to omega-3 FA in subgroups with different development stages of CHD, omega-3 FA supplementation application dose, diabetes, and sex. PROSPERO Registration Number: CRD42021282459. Results: This meta-analysis included 14 clinical RCTs, including 1,35,291 subjects. Omega-3 FA supplementation reduced the risk of MACE (RR; 0.95; CI: 0.91–0.99; p for heterogeneity 0.27; I2 = 20%; p = 0.03), cardiovascular death (RR; 0.94; CI: 0.89–0.99; p for heterogeneity 0.21; I2 = 25%; p = 0.02), and MI (RR; 0.86; CI: 0.79–0.93; p for heterogeneity 0.28; I2 = 19%; p < 0.01), but had no significant effect on all-cause death, stroke, and revascularization. In the subgroup analysis, omega-3 FA supplementation decreased the incidence of MACE and cardiovascular death in acute patients with MI, the risk of MI and stroke in patients with CHD, and the risk of MI in patients with high-risk CHD. 0.8–1.2 g omega-3 FA supplementation reduced the risk of MACE, cardiovascular death, and MI. It was revealed that gender and diabetes have no significant association between omega-3 FA supplementation and MACE risk. Conclusions: Omega-3 FA supplementation had a positive effect in reducing the incidence of MACE, cardiovascular death, MI. Regardless of the stage of CHD, omega-3 FA supplementation can prevent the occurrence of MI. The 0.8–1.2 g omega-3 FA supplementation alleviated CHD risk more effectively than lower or higher doses. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42021282459.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnut.2022.809311

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow diagram of the study selection process.
Figure 1 Flow diagram of the study selection process.CC BY · PubMed Central
Figure 2 Risk of bias plot. (A) Risk of bias summary; (B) risks of bias of each included study.
Figure 2 Risk of bias plot. (A) Risk of bias summary; (B) risks of bias of each included study.CC BY · PubMed Central
Figure 3 Forest plot of all-cause death and the detection of publication bias. (A) Forest plot of all-cause death; (B) funnel chart.
Figure 3 Forest plot of all-cause death and the detection of publication bias. (A) Forest plot of all-cause death; (B) funnel chart.CC BY · PubMed Central
Figure 4 Comparison of omega-3 FA supplementation vs. control group on the risks of (A) MACE; (B) CV death; (C) MI. MACEs, major adverse cardiovascular events; CV death, cardiovascular death; MI, myocardial infarction.
Figure 4 Comparison of omega-3 FA supplementation vs. control group on the risks of (A) MACE; (B) CV death; (C) MI. MACEs, major adverse cardiovascular events; CV death, cardiovascular death; MI, myocardial infarction.CC BY · PubMed Central
Figure 5 Forest plot of subgroup of subjects with MI, CHD, and high risks of CHD. MI: myocardial infarction; CHD: coronary heart disease; MACEs, major adverse cardiovascular events; CV death, cardiovascular death. *Random-effects model.
Figure 5 Forest plot of subgroup of subjects with MI, CHD, and high risks of CHD. MI: myocardial infarction; CHD: coronary heart disease; MACEs, major adverse cardiovascular events; CV death, cardiovascular death. *Random-effects model.CC BY · PubMed Central
Figure 6 Forest plot of subgroup of the application dose of omega-3 FA, diabetes or not, and sex. MACEs, major adverse cardiovascular events; CV death, cardiovascular death; MI, myocardial infarction. *Random-effects model.
Figure 6 Forest plot of subgroup of the application dose of omega-3 FA, diabetes or not, and sex. MACEs, major adverse cardiovascular events; CV death, cardiovascular death; MI, myocardial infarction. *Random-effects model.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Cited by

Metadata

Authors
Shen, S., Gong, C., Jin, K., Zhou, L., Xiao, Y., & Ma, L.
Venue
Frontiers in Nutrition
Published
2022-02-03
Volume
9
ISSN
2296-861X
Cited by
59
References
39
Funders
National Natural Science Foundation of China (81870192, 82170263)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.